2m 2m 2m 2m 2m 2m 2m
ADC Therapeutic N (ADCT)
NYSE
$1.13-$0.02 (-2.17%)
Price as of Jun 23, 2026 7:43 PM EDT- $141.4MMarket Cap
- -59.33%1-Year Change
- BiotechnologyIndustry
ADC Therapeutic N (ADCT)
$1.13-$0.02 (-2.17%)
ADCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.15 | ||
Change | $0.00 (0.00%) | ||
Open | $1.08 | ||
High | $1.17 | ||
Low | $1.06 | ||
Previous Close | $1.09 | ||
Volume | 1,049,831 | ||
30-Day Average Volume | 3,225,011 | ||
1-Week Change | 3.81% | ||
1-Month Change | -67.85% | ||
1-Year Change | -59.33% | ||
3-Year Change | -49.07% | ||
5-Year Change | -95.63% | ||
Fundamentals | |||
Shares Outstanding | 129.7M | ||
Total Assets | $291.5M | ||
Market Cap | $141.4M | ||
Enterprise Value | $26.1M | ||
Period: QTR TTM FY | |||
Revenue | $20.9M | ||
Net Income | -$33.0M | ||
Free Cash Flow | -$29.7M | ||
EBIT | -$29.3M | ||
EBITDA | -$29.3M | ||
Net Working Capital | $209.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 1 | ||
P/B | -1 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/10/2005 | ||
Earnings & Revenue